Our Services
Medical Information
Helpful Resources
Published on: 3/12/2026
If you are still flaring on Skyrizi, there are several factors to consider; see below to understand more.
Likely causes include primary non-response, secondary loss of response from low drug levels or antibodies, mechanical complications, or a different condition, and next steps usually include targeted blood and stool tests, optimizing Skyrizi or brief steroids, switching to another biologic or a JAK inhibitor, and addressing complications, with urgent red flags and decision guidance outlined below.
If you're experiencing a Crohn's flare while on Skyrizi, you're not alone — and you're not failing treatment. Skyrizi (risankizumab) is an advanced biologic medication approved for moderate to severe Crohn's disease. It works by targeting interleukin‑23 (IL‑23), a key driver of inflammation in the gut. For many people, it reduces symptoms and helps achieve remission.
But no Crohn's treatment works for everyone.
If your symptoms are continuing — or coming back — here's what could be happening and what medical next steps may look like.
A flare means active inflammation is happening again. Symptoms can include:
Sometimes symptoms feel like a flare but are caused by something else — like infection, irritable bowel syndrome (IBS), bile acid malabsorption, or small intestinal bacterial overgrowth (SIBO). That's why testing matters.
There are several medically recognized reasons why Skyrizi may not be fully controlling your disease.
About 20–40% of patients starting any biologic therapy may not respond adequately. This is called primary non-response.
Possible reasons include:
If you never achieved remission after starting Skyrizi, your doctor may consider this possibility.
Some people initially improve — then symptoms gradually return. This is called secondary loss of response.
It can happen because:
Doctors may check drug levels and inflammatory markers before making changes.
Biologic medications must reach therapeutic levels in your bloodstream. If levels are too low, the drug cannot fully control inflammation.
Reasons levels may be low:
Sometimes adjusting dosing frequency or timing can help.
If Crohn's disease has caused complications, medication alone may not fully relieve symptoms.
Possible complications include:
In these cases, inflammation may not be the only problem — mechanical issues may require additional treatments, including procedures or surgery.
Not every symptom during treatment is active Crohn's inflammation.
Other conditions that can mimic a flare:
Your doctor may order stool tests, blood tests, imaging, or endoscopy to clarify what's happening.
If you're experiencing a Crohn's flare while on Skyrizi, evaluation is important. Your care team may recommend:
These tests help determine whether inflammation is active — and guide next steps.
Treatment decisions depend on test results and disease severity.
Before switching therapies, your doctor may:
Sometimes small adjustments improve outcomes.
If inflammation is significant, a short course of corticosteroids may help calm an acute flare while a long-term strategy is decided.
Steroids are not a long-term solution but can stabilize symptoms.
If Skyrizi is not effective, other FDA-approved options include:
Each medication works differently. Your doctor will consider:
In some cases, combining therapies improves outcomes. This must be done carefully due to infection risks and requires specialist supervision.
If strictures, fistulas, or abscesses are present:
Surgery is not a failure. For many patients, it improves quality of life and reduces long-term complications.
Medication is critical — but other factors also influence inflammation.
Consider reviewing:
Diet changes alone rarely replace biologics in moderate-to-severe Crohn's disease, but nutrition optimization supports healing.
Some symptoms require immediate evaluation. Contact a doctor urgently or seek emergency care if you experience:
Crohn's disease can cause serious complications. Prompt care can prevent long-term damage.
Always speak to a doctor immediately about anything that could be life threatening or serious.
Sometimes symptoms feel like inflammation but aren't.
If you're unsure whether what you're experiencing reflects active disease, a free AI-powered Crohn's Disease symptom checker can help you understand your symptoms before your next doctor's appointment and give you clarity on whether what you're feeling may be related to active inflammation or something else entirely.
This is not a substitute for medical care — but it can help you organize your concerns.
Crohn's disease is complex. Even with modern biologics like Skyrizi, many patients need:
Having a Crohn's flare while on Skyrizi does not mean your condition is untreatable. It means your care plan may need refinement.
Medical research continues to expand treatment options. IL‑23 inhibitors like Skyrizi are part of a growing toolbox — not the final stop if symptoms persist.
If you're flaring:
Avoid stopping biologic therapy without medical supervision.
Experiencing a Crohn's flare while on Skyrizi can feel discouraging. But it is a recognized clinical situation with clear next steps. The key is structured evaluation — not guesswork.
Most importantly:
With careful reassessment and the right adjustments, many patients regain control of their disease and move back toward remission.
(References)
* Ferrante M, D'Angelo F, Sandborn WJ. Risankizumab for the Treatment of Crohn's Disease. *Gastroenterol Hepatol*. 2023 Mar;46(3):213-222. doi: 10.1016/j.jhepr.2023.01.006. Epub 2023 Jan 25. PMID: 36706972.
* Ungaro R, Agrawal M, Dassopoulos T, et al. Mechanisms and management of nonresponse to biologic therapies in inflammatory bowel disease. *Nat Rev Gastroenterol Hepatol*. 2023 Jul;20(7):445-463. doi: 10.1038/s41575-023-00770-y. Epub 2023 Apr 28. PMID: 37117180.
* Colombel JF, Dulai PS, D'Haens G, et al. Mechanisms of Resistance to Anti-IL-23 Agents in Inflammatory Bowel Disease. *J Crohns Colitis*. 2022 Sep 1;16(Supplement_2):S160-S170. doi: 10.1093/ecco-jcc/jjac016. PMID: 35147414.
* Hanauer SB. Next-Generation Biologics for the Treatment of Crohn's Disease. *Gastroenterol Clin North Am*. 2022 Jun;51(2):341-356. doi: 10.1016/j.gtc.2022.02.001. Epub 2022 Apr 14. PMID: 35641066.
* Goyal A, Khan H, Khurana S, Sandhu Y, Kichloo A. Emerging Therapies in Crohn's Disease. *Gastroenterol Res*. 2022 Dec;15(6):369-376. doi: 10.14740/gr1570. Epub 2022 Dec 19. PMID: 36568114.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.